Literature DB >> 15600230

Agreement among subjective, objective, and collateral measures of insomnia in postwithdrawal recovering alcoholics.

Shawn R Currie1, Sonya Malhotra, Stewart Clark.   

Abstract

The level of agreement among objective, subjective, and collateral assessments of insomnia was examined in 56 recovering alcoholics. Participants underwent a multimodal sleep assessment protocol consisting of sleep logs, actigraph recordings, questionnaires, and collateral reports of insomnia severity. All sleep measures confirmed moderate to severe insomnia in the study sample. Over 1 week of simultaneous sleep log and actigraph recording, the average disagreement between methods ranged from 16 min for sleep onset latency to 1 hr for wake time after sleep onset. Interrater agreement for the severity of insomnia symptoms using the Sleep Impairment Index was poor for subject-clinician, subject-collateral, and collateral-clinician rating pairs (intraclass correlation coefficients < .35). In general, recovering alcoholics' self-reported sleep reflected a greater severity of insomnia symptoms than did the actigraph and collateral measures. Given that such high levels of disagreement can occur in individual participants, researchers are advised to use a combination of sleep measures to assess insomnia in this population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15600230     DOI: 10.1207/s15402010bsm0203_4

Source DB:  PubMed          Journal:  Behav Sleep Med        ISSN: 1540-2002            Impact factor:   2.964


  14 in total

1.  Rest/activity rhythm is related to the coexistence of pain and sleep disturbance among advanced cancer patients with pain.

Authors:  Chen-Lai Ma; Wen-Pei Chang; Chia-Chin Lin
Journal:  Support Care Cancer       Date:  2013-09-01       Impact factor: 3.603

2.  Perception of sleep in recovering alcohol-dependent patients with insomnia: relationship with future drinking.

Authors:  Deirdre A Conroy; J Todd Arnedt; Kirk J Brower; Stephen Strobbe; Flavia Consens; Robert Hoffmann; Roseanne Armitage
Journal:  Alcohol Clin Exp Res       Date:  2006-12       Impact factor: 3.455

3.  Time estimation in good and poor sleepers.

Authors:  Catherine S Fichten; Laura Creti; Rhonda Amsel; Sally Bailes; Eva Libman
Journal:  J Behav Med       Date:  2005-11-30

4.  Day-to-day variability in nap duration predicts medical morbidity in older adults.

Authors:  Natalie D Dautovich; Daniel B Kay; Michael L Perlis; Joseph M Dzierzewski; Meredeth A Rowe; Christina S McCrae
Journal:  Health Psychol       Date:  2012-02-27       Impact factor: 4.267

5.  Effect of night smoking, sleep disturbance, and their co-occurrence on smoking outcomes.

Authors:  Erica N Peters; Lisa M Fucito; Claire Novosad; Benjamin A Toll; Stephanie S O'Malley
Journal:  Psychol Addict Behav       Date:  2011-06

Review 6.  (Mis)perception of sleep in insomnia: a puzzle and a resolution.

Authors:  Allison G Harvey; Nicole K Y Tang
Journal:  Psychol Bull       Date:  2011-10-03       Impact factor: 17.737

7.  Cognitive-behavioral therapy for insomnia in alcohol dependent patients: a randomized controlled pilot trial.

Authors:  J Todd Arnedt; Deirdre A Conroy; Roseanne Armitage; Kirk J Brower
Journal:  Behav Res Ther       Date:  2011-02-15

8.  Trajectory of insomnia symptoms in older adults with lung cancer: using mixed methods.

Authors:  Grace E Dean; Patricia Ziegler; Hongbin Chen; Lynn M Steinbrenner; Suzanne S Dickerson
Journal:  Support Care Cancer       Date:  2018-10-15       Impact factor: 3.603

9.  Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial.

Authors:  Peter D Friedmann; Jennifer S Rose; Robert Swift; Robert L Stout; Richard P Millman; Michael D Stein
Journal:  Alcohol Clin Exp Res       Date:  2008-07-08       Impact factor: 3.455

10.  A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.

Authors:  Kirk J Brower; Hyungjin Myra Kim; Stephen Strobbe; Maher A Karam-Hage; Flavia Consens; Robert A Zucker
Journal:  Alcohol Clin Exp Res       Date:  2008-06-06       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.